{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T15:58:10Z","timestamp":1760975890248,"version":"3.44.0"},"reference-count":98,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780702040870"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/b978-0-7020-4087-0.00072-3","type":"book-chapter","created":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T03:16:45Z","timestamp":1387595805000},"page":"1073-1081","source":"Crossref","is-referenced-by-count":14,"title":["Chronic myeloproliferative diseases"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.2830470205","article-title":"Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935\u20131989","volume":"47","author":"An\u00eda","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jnnp.27.4.313","article-title":"Spinal cord compression by extramedullary haematopoiesis in myelosclerosis","volume":"27","author":"Appleby","year":"1964","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0015","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/01.STR.26.8.1463","article-title":"Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases","volume":"26","author":"Arboix","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/1881165a0","article-title":"A possible specific chromosome abnormality in human chronic myeloid leukaemia","volume":"188","author":"Baikie","year":"1960","journal-title":"Nature"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0025","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0889-8588(03)00080-7","article-title":"Myelofibrosis with myeloid metaplasia","volume":"17","author":"Barosi","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.seminhematol.2005.05.018","article-title":"Idiopathic myelofibrosis","volume":"42","author":"Barosi","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/asheducation-2009.1.621","article-title":"Pathogenesis and management of essential thrombocythemia","volume":"2009","author":"Beer","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1160\/TH08-02-0081","article-title":"The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder","volume":"99","author":"Bellucci","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-510X(99)00302-0","article-title":"Neuromyotonia in association with essential thrombocythemia","volume":"173","author":"Benito-Le\u00f3n","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0050","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0055","series-title":"Polycythemia Vera and the Myeloproliferative Disorders","first-page":"166","article-title":"Treatment of polycythemia vera: a summary of clinical trials conducted by the Polycythemia Vera Study Group","author":"Berk","year":"1995"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0060","first-page":"339","article-title":"Diagnosis and classification of the polycythemias","volume":"12","author":"Berlin","year":"1975","journal-title":"Semin Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0303-8467(00)00072-X","article-title":"Lower motor neuron disease associated with myelofibrosis","volume":"102","author":"Bir","year":"2000","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-2-3","article-title":"Essential thrombocythemia","volume":"2","author":"Bri\u00e8re","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000115674","article-title":"Chorea and polycythaemia","volume":"23","author":"Bryn","year":"1984","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0080","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.5858\/2006-130-1126-PV","article-title":"Polycythemia vera: new clinicopathologic perspectives","volume":"130","author":"Cao","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000204873","article-title":"Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients","volume":"85","author":"Cervantes","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.1997.782714.x","article-title":"Identification of \u201cshort-lived\u201d and \u201clong-lived\u201d patients at presentation of idiopathic myelofibrosis","volume":"97","author":"Cervantes","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0095","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1365-2141.2002.03688.x","article-title":"Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients","volume":"118","author":"Cervantes","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.leu.2404048","article-title":"Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution","volume":"20","author":"Cervantes","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0105","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"4","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3171\/jns.1993.79.1.0125","article-title":"Progressive paraparesis due to thoracic extramedullary hematopoiesis in myelofibrosis","volume":"79","author":"De Klippel","year":"1993","journal-title":"J Neurosurg"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000203792","article-title":"Spinal cord compression due to extramedullary hematopoiesis in the proliferative phase of polycythemia vera","volume":"96","author":"De Morais","year":"1996","journal-title":"Acta Heamatol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1160\/TH08-04-0205","article-title":"The JAK2 V617F mutation in patients with cerebral venous thrombosis: a rebuttal","volume":"99","author":"De Stefano","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0135","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ajh.22024","article-title":"The JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis","volume":"86","author":"De Stefano","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0140","first-page":"29","article-title":"Focal extra-axial hemorrhagic mass with subdural hemorrhage secondary to extramedullary haematopoiesis in idiopathic myelodysplasic syndrome","volume":"51","author":"Di Leva","year":"2007","journal-title":"J Neurosurg Sci"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/cncr.21644","article-title":"Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system","volume":"106","author":"Dingli","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.1840170214","article-title":"Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations","volume":"17","author":"Dubois","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0155","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0165","first-page":"233","article-title":"Haemorrhagische thrombocythamie bei vascularer schrumpfmilz","volume":"293","author":"Epstein","year":"1934","journal-title":"Virchov\u2019s Archiv Abteilung"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0170","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.lpm.2009.02.018","article-title":"Infarctus m\u00e9dullaire r\u00e9v\u00e9lant une thrombocyt\u00e9mie essentielle","volume":"38","author":"Faivre","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0175","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2796.1993.tb01019.x","article-title":"Polycythemia vera and cerebral blood flow: a preliminary study with transcranial doppler","volume":"234","author":"Fiermonte","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0185","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3346\/jkms.2007.22.6.1090","article-title":"Chronic idiopathic myelofibrosis presenting as cauda equina compression due to extramedullary hematopoiesis: a case report","volume":"22","author":"Goh","year":"2007","journal-title":"Korean Med Sci"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0035-3787(04)71140-6","article-title":"Infarctus c\u00e9r\u00e9braux art\u00e9riels d\u2019origine h\u00e9matologique: exp\u00e9rience lausannoise et revue de la litt\u00e9rature","volume":"160","author":"Gonthier","year":"2004","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0195","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20 years","volume":"123","author":"Gruppo Italiano Studio Policitemia","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0200","first-page":"2831","volume":"93","author":"Guardiola","year":"1999","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0205","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.51.9.1219","article-title":"Cerebral venous thrombosis as presenting sign of myeloproliferative disorders","volume":"51","author":"Haan","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/asheducation-2010.1.129","article-title":"Rethinking disease definitions and therapeutic strategies in essential thrombocythemia and polycythemia vera","volume":"2010","author":"Harrison","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF01878089","article-title":"Zwei F\u00e4lle von Leuk\u00e4mie mit eigenth\u00fcmlichem Blut-resp Knochenmarksbefund","volume":"78","author":"Heuck","year":"1879","journal-title":"Virchows Arch (Pathol Anat)"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/asheducation-2007.1.346","article-title":"Biology and treatment of primary myelofibrosis","volume":"2007","author":"Hoffman","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0235","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jcp.56.2.154","article-title":"Myelofibrosis presenting as spinal cord compression","volume":"56","author":"Horwood","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0240","first-page":"210","article-title":"A case of dermatomyositis associated with chronic idiopathic myelofibrosis","volume":"46","author":"Ito","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5692\/clinicalneurol.51.211","article-title":"Case report of essential thrombocythemia with sudden onset of hemichorea","volume":"51","author":"Ito","year":"2011","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0250","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-99-4-513","article-title":"Neurologic manifestations of essential thrombocythemia","volume":"99","author":"Jabaily","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0255","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0404.2000.102005299.x","article-title":"Neurological complications of essential thrombocytosis (ET)","volume":"102","author":"Kesler","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10072-008-0994-2","article-title":"No evidence of perfusion abnormalities in the basal ganglia of a patient with generalized chorea-ballism and polycythaemia vera: analysis using subtraction SPECT co-registered to MRI","volume":"29","author":"Kim","year":"2008","journal-title":"Neurol Sci"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0270","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1161\/01.STR.0000174193.89864.55","article-title":"Moyamoya syndrome in an adolescent with essential thrombocythemia. Successful intracranial carotid stent placement","volume":"36","author":"Kornblihtt","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.3.5820.216","article-title":"Progressive Neurological deficits in primary polycythemia","volume":"3","author":"Kremer","year":"1972","journal-title":"BMJ"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0285","first-page":"1032","article-title":"Ischemic stroke as a presentation of essential thrombocythemia. Four case reports","volume":"38","author":"Mallada-Frechin","year":"2004","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0290","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2141.2005.05535.x","article-title":"Guidelines for the diagnosis, investigation and management of polycythemia\/erythrocytosis","volume":"130","author":"McMullin","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","article-title":"Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976\u20131995","volume":"61","author":"Mesa","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0300","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2004-07-2864","article-title":"Leukemic transformation in myelofibrosis with myeloid metaplasia: a single institution experience with 91 cases","volume":"105","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0305","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.22021","article-title":"Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic","volume":"107","author":"Mesa","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0310","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.43.6.1107","article-title":"Transient neurologic and ocular manifestations in primary thrombocythemia","volume":"43","author":"Michiels","year":"1993","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10428199609074362","article-title":"Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders","volume":"22","author":"Michiels","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"Suppl 1","key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0320","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10428199609074360","article-title":"Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia","volume":"22","author":"Michiels","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/09537100310001646969","article-title":"Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythemia vera","volume":"15","author":"Michiels","year":"2004","journal-title":"Platelets"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0330","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/09537100600758677","volume":"17","author":"Michiels","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0335","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2006-939431","article-title":"Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications","volume":"32","author":"Michiels","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0340","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp.2010.219956","article-title":"Essential thrombocythaemia and its neurological complications","volume":"10","author":"Miller","year":"2010","journal-title":"Pract Neurol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0345","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.110.581223","article-title":"Venous thromboembolic events after cerebral vein thrombosis","volume":"41","author":"Miranda","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0350","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1179\/016164104225015985","article-title":"Progressive occlusive disease of large cerebral arteries and ischemic events in a patient with essential thrombocythemia","volume":"26","author":"Mosso","year":"2004","journal-title":"Neurol Res"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0355","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/pmj.76.900.658","article-title":"Chorea disclosing deterioration of polycythemia vera","volume":"76","author":"Nazabal","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0360","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000441-190308000-00001","article-title":"Chronic cyanosis, with polycythaemia and enlarged spleen: a new clinical entity","volume":"126","author":"Osler","year":"1903","journal-title":"Am J Med Sci"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0365","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archneur.1980.00500550091019","article-title":"Spinal cord compression with paraplegia in myelofibrosis","volume":"37","author":"Oustwani","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0370","first-page":"13","article-title":"Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia","volume":"88","author":"Passamonti","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0375","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0380","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0385","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1160\/TH08-09-0570","article-title":"Myelofibrosis and spinal cord ischemia","volume":"101","author":"Periad","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0390","first-page":"499","article-title":"Polycythemia vera: clinical studies on a series of 127 patients managed without radiation therapy","volume":"33","author":"Perkins","year":"1964","journal-title":"Q J Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0395","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.eye.6702371","article-title":"Third nerve paralysis as a presenting sign of essential thrombocythaemia","volume":"20","author":"Prabhakaran","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0400","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.410070115","article-title":"Extramedullary hematopoiesis and spinal cord compression complicating polycythemia rubra vera","volume":"7","author":"Rice","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0405","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0002-9343(66)90081-7","article-title":"Hemodynamic studies of the portal circulation in myeloid metaplasia","volume":"41","author":"Rosenbaum","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0410","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1212\/WNL.22.6.567","article-title":"Unusual radiologic and neurologic findings in a case of myelofibrsis with extramedullary hematopoiesis","volume":"22","author":"Rutman","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0415","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jcp.2007.053751","article-title":"Polycythaemia rubra vera and myelofibrosis with spinal cord compression","volume":"61","author":"Scott","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0420","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","article-title":"Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia","volume":"108","author":"Scott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0425","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0430","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1309\/AJCP7VO4HAIZYATP","article-title":"JAK2 mutations across a spectrum of venous thrombosis cases","volume":"134","author":"Shetty","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0435","doi-asserted-by":"crossref","first-page":"909","DOI":"10.7326\/0003-4819-57-6-909","article-title":"Neurologic complications of polycythemia","volume":"57","author":"Silverstein","year":"1962","journal-title":"Ann Intern Med"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0440","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera: myths, mechanisms and management","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0445","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/asheducation-2003.1.200","article-title":"Chronic myeloproliferative disorders","volume":"2003","author":"Spivak","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0450","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.21946","article-title":"Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"Tefferi","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0455","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2141.2001.02796.x","article-title":"Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia","volume":"113","author":"Tefferi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0460","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2006-12-062125","article-title":"Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation","volume":"110","author":"Theocharides","year":"2007","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0465","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(77)90179-9","article-title":"Cerebral blood-flow in polycythemia","volume":"2","author":"Thomas","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0470","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb9000","first-page":"384","article-title":"Sur une forme sp\u00e9ciale de cyanose s\u2019acccompagnant d\u2019hyperglobulie excessive et persistant","volume":"44","author":"Vaquez","year":"1892","journal-title":"CR Soc Biol (Paris)"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0475","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-197109000-00001","article-title":"The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome","volume":"50","author":"Ward","year":"1971","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0480","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01707281","article-title":"Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients","volume":"63","author":"Wehmeier","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0485","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4065\/81.2.159","article-title":"Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors","volume":"81","author":"Wolanskyj","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/B978-0-7020-4087-0.00072-3_bb0490","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.33.2.139","article-title":"Peripheral neuropathy associated with polycythemia vera","volume":"33","author":"Yiannikas","year":"1983","journal-title":"Neurology"}],"container-title":["Handbook of Clinical Neurology","Neurologic Aspects of Systemic Disease Part II"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780702040870000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780702040870000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:33:26Z","timestamp":1757540006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780702040870000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9780702040870"],"references-count":98,"URL":"https:\/\/doi.org\/10.1016\/b978-0-7020-4087-0.00072-3","relation":{},"ISSN":["0072-9752"],"issn-type":[{"type":"print","value":"0072-9752"}],"subject":[],"published":{"date-parts":[[2014]]}}}